State of New Jersey Common Pension Fund D Sells 2,319 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

State of New Jersey Common Pension Fund D lessened its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 7.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 27,382 shares of the company’s stock after selling 2,319 shares during the period. State of New Jersey Common Pension Fund D owned 0.06% of Prestige Consumer Healthcare worth $1,974,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of PBH. Opal Wealth Advisors LLC acquired a new stake in shares of Prestige Consumer Healthcare in the second quarter worth about $26,000. Quest Partners LLC raised its stake in shares of Prestige Consumer Healthcare by 2,826.7% in the 2nd quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after acquiring an additional 424 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in Prestige Consumer Healthcare by 80.6% in the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock worth $33,000 after purchasing an additional 208 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in Prestige Consumer Healthcare by 562.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock worth $35,000 after purchasing an additional 433 shares during the period. Finally, Gladius Capital Management LP acquired a new position in Prestige Consumer Healthcare during the second quarter valued at approximately $35,000. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Stock Performance

PBH opened at $82.36 on Monday. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61. The stock’s 50 day moving average price is $73.29 and its two-hundred day moving average price is $70.24. The firm has a market capitalization of $4.07 billion, a P/E ratio of 20.04, a price-to-earnings-growth ratio of 2.32 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 12-month low of $56.61 and a 12-month high of $83.83.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.09. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The business had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. During the same quarter last year, the company posted $1.07 earnings per share. Prestige Consumer Healthcare’s quarterly revenue was down .9% on a year-over-year basis. On average, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current year.

Insiders Place Their Bets

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 9,885 shares of Prestige Consumer Healthcare stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $81.97, for a total transaction of $810,273.45. Following the sale, the senior vice president now owns 18,835 shares in the company, valued at $1,543,904.95. The trade was a 34.42 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider William P’pool sold 8,987 shares of the business’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $81.85, for a total transaction of $735,585.95. Following the completion of the sale, the insider now directly owns 20,058 shares in the company, valued at $1,641,747.30. This trade represents a 30.94 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,935 shares of company stock worth $2,289,025 in the last ninety days. Insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on PBH shares. DA Davidson restated a “buy” rating and issued a $95.00 price objective on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. Jefferies Financial Group reiterated a “hold” rating and issued a $76.00 target price (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. One research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $83.67.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.